| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | B S Meldrum | |
| P433 | issue | 11 Suppl 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | S14-23 | |
| P577 | publication date | 1994-11-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | The role of glutamate in epilepsy and other CNS disorders | |
| P478 | volume | 44 |
| Q50533164 | 2R,4R-APDC, a Metabotropic Glutamate Receptor Agonist, Reduced Neuronal Apoptosis by Upregulating MicroRNA-128 in a Rat Model After Seizures |
| Q59806794 | A Light-Controlled Allosteric Modulator Unveils a Role for mGlu Receptors During Early Stages of Ischemia in the Rodent Cerebellar Cortex |
| Q41917625 | A combination of NMDA and AMPA receptor antagonists retards granule cell dispersion and epileptogenesis in a model of acquired epilepsy |
| Q36261497 | Abnormal glutamate release in aged BTBR mouse model of autism |
| Q28539687 | Acacetin inhibits glutamate release and prevents kainic acid-induced neurotoxicity in rats |
| Q37383662 | Acute alcohol action and desensitization of ligand-gated ion channels |
| Q24613056 | Af9/Mllt3 interferes with Tbr1 expression through epigenetic modification of histone H3K79 during development of the cerebral cortex |
| Q34061709 | Agmatine reduces extracellular glutamate during pentylenetetrazole-induced seizures in rat brain: a potential mechanism for the anticonvulsive effects |
| Q36499746 | Agonists and antagonists of metabotropic glutamate receptors: anticonvulsants and antiepileptogenic agents? |
| Q48933212 | Altered expression of synaptotagmin I in temporal lobe tissue of patients with refractory epilepsy. |
| Q42470115 | An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons |
| Q36348581 | BIG1 is required for the survival of deep layer neurons, neuronal polarity, and the formation of axonal tracts between the thalamus and neocortex in developing brain |
| Q37885227 | Behavioral and neurochemical effects of proline |
| Q46681661 | Behavioral characterization of GLT1 (+/-) mice as a model of mild glutamatergic hyperfunction. |
| Q45969415 | Beta-amyloid precursor protein (APP) and APP-RNA are rapidly affected by glutamate in cultured neurons: selective increase of mRNAs encoding a Kunitz protease inhibitor domain. |
| Q40103227 | Brain Tumor-Related Epilepsy: a Current Review of the Etiologic Basis and Diagnostic and Treatment Approaches |
| Q37282869 | Brain proteomics supports the role of glutamate metabolism and suggests other metabolic alterations in protein l-isoaspartyl methyltransferase (PIMT)-knockout mice |
| Q26770781 | Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence? |
| Q48163831 | Chronic Treatment with a Clinically Relevant Dose of Methylphenidate Increases Glutamate Levels in Cerebrospinal Fluid and Impairs Glutamatergic Homeostasis in Prefrontal Cortex of Juvenile Rats. |
| Q34967718 | Conantokin-Br from Conus brettinghami and selectivity determinants for the NR2D subunit of the NMDA receptor |
| Q33239974 | Convulsant bicuculline modifies CNS muscarinic receptor affinity |
| Q46664910 | Differential and time-dependent changes in gene expression for type II calcium/calmodulin-dependent protein kinase, 67 kDa glutamic acid decarboxylase, and glutamate receptor subunits in tetanus toxin-induced focal epilepsy. |
| Q50743604 | Dynamic regulation of glycine-GABA co-transmission at spinal inhibitory synapses by neuronal glutamate transporter. |
| Q48600114 | Effect of gamma-decanolactone on glutamate binding in the rat cerebral cortex |
| Q46013187 | Effects of a single postnatal methamphetamine administration on NMDA-induced seizures are sex- and prenatal exposure-specific. |
| Q83745209 | Effects of antiepileptic drugs on glutamate release from rat and human neocortical synaptosomes |
| Q34442872 | Effects of cocaine-kindling on the expression of NMDA receptors and glutamate levels in mouse brain |
| Q44511068 | Evidence that hyperprolinemia alters glutamatergic homeostasis in rat brain: neuroprotector effect of guanosine |
| Q28075692 | Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents |
| Q55475337 | Extracellular glutamate and other metabolites in and around RG2 rat glioma: an intracerebral microdialysis study. |
| Q38235715 | Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilep |
| Q35331983 | Glutamate release by primary brain tumors induces epileptic activity |
| Q31165986 | Glutamate, T cells and multiple sclerosis |
| Q43697288 | Group I metabotropic glutamate receptors elicit epileptiform discharges in the hippocampus through PLCbeta1 signaling. |
| Q44969367 | Group I metabotropic glutamate receptors interfere in different ways with pentylenetetrazole seizures, kindling, and kindling-related learning deficits |
| Q28072158 | Guanosine: a Neuromodulator with Therapeutic Potential in Brain Disorders |
| Q36021545 | Histone deacetylase inhibitor SAHA attenuates post-seizure hippocampal microglia TLR4/MYD88 signaling and inhibits TLR4 gene expression via histone acetylation |
| Q43181358 | Imaging in vivo glutamate fluctuations with [(11)C]ABP688: a GLT-1 challenge with ceftriaxone |
| Q46599565 | Increase of adenine nucleotide hydrolysis in rat hippocampal slices after seizures induced by quinolinic acid |
| Q59340029 | Increased susceptibility to cortical spreading depression and epileptiform activity in a mouse model for FHM2 |
| Q43910165 | Influence of convulsants on rat brain activities of alanine aminotransferase and aspartate aminotransferase. |
| Q45239577 | Influence of proline on rat brain activities of alanine aminotransferase, aspartate aminotransferase and acid phosphatase |
| Q50133892 | Interactions Between Epilepsy and Plasticity |
| Q46366822 | Intracerebroventricular guanine-based purines protect against seizures induced by quinolinic acid in mice |
| Q60931365 | Investigating the role of interleukin-1 beta and glutamate in inflammatory bowel disease and epilepsy using discovery browsing |
| Q34006439 | Lamotrigine. A review of its use in childhood epilepsy |
| Q40932340 | Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy |
| Q73133794 | Long-lasting ibogaine protection against NMDA-induced convulsions in mice |
| Q42574429 | Low micromolar Ba(2+) potentiates glutamate transporter current in hippocampal astrocytes |
| Q39016527 | Microsensors for in vivo Measurement of Glutamate in Brain Tissue |
| Q83943629 | Modulation of anticonvulsant effects of cannabinoid compounds by GABA-A receptor agonist in acute pentylenetetrazole model of seizure in rat |
| Q35541437 | Myricetin inhibits the release of glutamate in rat cerebrocortical nerve terminals. |
| Q37589114 | NADPH oxidase in brain injury and neurodegenerative disorders |
| Q59127756 | Neuromodulatory Effects of Guanine-Based Purines in Health and Disease |
| Q57178735 | Neuroprotective Effects of Guanosine Administration on In Vivo Cortical Focal Ischemia in Female and Male Wistar Rats |
| Q39253539 | Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) |
| Q46772873 | Occurrence of bicuculline-, NMDA- and kainic acid-induced seizures in prenatally methamphetamine-exposed adult male rats. |
| Q51734185 | Overexpression of selenoprotein H prevents mitochondrial dynamic imbalance induced by glutamate exposure. |
| Q36409596 | Overview of Glutamatergic Dysregulation in Central Pathologies |
| Q26778466 | PET studies in epilepsy |
| Q35722682 | PRRT2 Mutant Leads to Dysfunction of Glutamate Signaling |
| Q38217449 | Peritumoral epilepsy: relating form and function for surgical success. |
| Q37739145 | Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish. |
| Q41737249 | Phospho-dependent Accumulation of GABABRs at Presynaptic Terminals after NMDAR Activation. |
| Q35812916 | Potential role of Plasmodium falciparum-derived ammonia in the pathogenesis of cerebral malaria |
| Q47646934 | Prenatal alcohol exposure enhances the susceptibility to NMDA-induced generalized tonic-clonic seizures in developing rats |
| Q37333350 | Presynaptic NMDA receptors: newly appreciated roles in cortical synaptic function and plasticity |
| Q38410871 | Researching glutamate - induced cytotoxicity in different cell lines: a comparative/collective analysis/study |
| Q79760124 | Restoration and putative protection in Parkinsonism |
| Q48703365 | Secondary activation of a cation conductance is responsible for NMDA toxicity in acutely isolated hippocampal neurons |
| Q35073006 | Selective injection system into hippocampus CA1 via monitored theta oscillation |
| Q37000551 | Sigma receptors [σRs]: biology in normal and diseased states |
| Q88530856 | Statin use associated with lower risk of epilepsy after intracranial haemorrhage: A population-based cohort study |
| Q83242669 | Study of epileptiform activity in cerebral ganglion of mud crab Scylla serrata |
| Q24538432 | The alkaloid alstonine: a review of its pharmacological properties |
| Q34061442 | The effect of right vagus nerve stimulation on focal cerebral ischemia: an experimental study in the rat. |
| Q43985718 | The effects of vigabatrin on electrophysiology and visual fields in epileptics: a controlled study with a discussion of possible mechanisms |
| Q36795785 | The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect |
| Q34262821 | The role of gap junction channels during physiologic and pathologic conditions of the human central nervous system |
| Q36003895 | The role of group I metabotropic glutamate receptors in neuronal excitotoxicity in Alzheimer's disease |
| Q46274795 | Two types of seizures in homocysteine thiolactone-treated adult rats, behavioral and electroencephalographic study |
| Q73256795 | Upregulation of NMDA receptors in hippocampus and cortex in the pentylenetetrazol-induced "kindling" model of epilepsy |
| Q42001212 | Use of the hydantoin isostere to produce inhibitors showing selectivity toward the vesicular glutamate transporter versus the obligate exchange transporter system x(c)(-) |
| Q57048955 | Wwox deletion leads to reduced GABA-ergic inhibitory interneuron numbers and activation of microglia and astrocytes in mouse hippocampus |
Search more.